Search clinical trials for: FCN-437c, Letrozole or anastrozole, Goserelin acetate
Total 68 results
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Ahon Pharmaceutical Co., Ltd.CompletedAdvanced Breast CancerChina
-
Ahon Pharmaceutical Co., Ltd.Affiliated Hospital of Hebei University; The First Hospital of Jilin University and other collaboratorsRecruiting
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Novartis PharmaceuticalsActive, not recruiting
-
Washington University School of MedicineNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnBreast CancerUnited States
-
Imperial College LondonAstraZeneca; Cancer Research UKCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
Ahon Pharmaceutical Co., Ltd.Zhejiang Cancer Hospital; Fudan University; Sir Run Run Shaw HospitalUnknown
-
IRCCS Azienda Ospedaliera Universitaria San Martino...Clinical Research Technology S.r.l.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingNeoplasms | Breast Cancer | Breast DiseasesChina
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Hormone Receptor Positive TumorSweden
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
AstraZenecaCompleted
-
University of WashingtonNational Cancer Institute (NCI)Terminated
-
International Cancer Research Group, United Arab...King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut... and other collaboratorsRecruitingHormonal Receptors Positive, HER2 Negative, Advanced Breast CancerAlgeria, Jordan, Saudi Arabia
-
National Cancer Institute (NCI)TerminatedRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu NegativeUnited States
-
Peking Union Medical College HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
-
Fuzhou General HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive TumorChina
-
Inge Marie SvaneWithdrawn
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom
-
UNICANCERPfizerActive, not recruitingMetastatic Breast CancerFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaboratorsActive, not recruitingProstate CancerUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Russian Federation, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Finland, Peru, Colombia, Portugal, Canada, Brazil, India, Argentina, Costa Rica
-
Institut Claudius RegaudCompletedHormono-depending Adjuvant Breast CancerFrance
-
Yazd Research & Clinical Center for InfertilityCompleted
-
Ruth O'ReganUniversity of Rochester; Puma Biotechnology, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
Shayna Showalter, MDActive, not recruitingBreast Cancer FemaleUnited States
-
The Netherlands Cancer InstituteTerminated
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer | Neoadjuvant Endocrine TherapyRussian Federation
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingBreast CancerUnited States, Spain, Korea, Republic of, China, France, Germany, Japan, Italy, Belgium, Australia, United Kingdom, Canada, Singapore
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast CarcinomaUnited States
-
Fudan UniversityUnknown
-
Fudan UniversityRecruiting
-
Novartis PharmaceuticalsSuspendedEarly Breast CancerAustralia
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Novartis PharmaceuticalsCompletedHR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerCanada
-
National Institute of Diabetes and Digestive and...American Diabetes AssociationSuspended
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, Korea, Republic of, Poland, Taiwan, Singapore, Japan, South Africa, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Washington University School of MedicineGenomic Health®, Inc.RecruitingBreast Cancer | Breast Neoplasms | Cancer of Breast | Cancer of the BreastUnited States
-
UNICANCERTerminated
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Estrogen Receptor Positive TumorSweden
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Instituto Nacional de Cancer, BrazilCancer Research UK Cambridge InstituteUnknown
-
Technical University of MunichUnknown